Heparin Dose-Response Curve for Heparin Dose Determination During Cardiopulmonary Bypass for Pediatric Cardiac Surgery: A Prospective Randomized Controlled Study.
Pavana Gokhale, Suruchi Hasija, Arindam Choudhury et al.
✦ AI-curated · Sources linked
In 30 seconds
This prospective randomized controlled trial evaluated individualized heparin dosing guided by a heparin dose-response (HDR) curve in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass. The study found that HDR achieved target activated clotting time (ACT) of ≥480 seconds in 72.2% of patients compared to 83.3% in the conventional dosing group. HDR was associated with lower heparin exposure and reduced postoperative blood loss.
Key findings
- HDR achieved target ACT in 72.2% of patients versus 83.3% in the control group (p = 0.396).
- HDR group received significantly less heparin (260 IU/kg vs 420 IU/kg; p < 0.001).
- Lower protamine use was noted in the HDR group (4.1 mg/kg vs 4.8 mg/kg; p = 0.002).
- HDR was associated with reduced 24-hour blood loss (5.2 mL/kg vs 6.5 mL/kg; p = 0.03).
Why it matters
Understanding the efficacy of individualized heparin dosing in pediatric cardiac surgery is crucial for optimizing anticoagulation strategies, potentially leading to improved patient outcomes and reduced complications related to bleeding and transfusion.